HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
HTL was pleased to share that Antoine Clavier-Choo, HTL head of Asia Pacific, participated in CPHI Japan, one of the largest pharmaceutical events in Asia.
The event was held on April 19-21, 2023, at the Tokyo Big Sight Exhibition Center.
CPHI Japan provided an excellent opportunity for us to network with industry experts, customers, and explore new partnerships and collaborations.
We were excited to learn about the latest trends and innovations in the pharmaceutical industry and share our knowledge and experience with others.
We’re pleased to share our second CSR report, highlighting the actions and commitments we carried out throughout 2024.
A Global Scientific Gathering Dedicated to Hyaluronic Acid Innovation.
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.